StockNews.com assumed coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a report released on Wednesday. The firm issued a sell rating on the biotechnology company’s stock.
NanoString Technologies Price Performance
The stock’s 50 day moving average is $0.36 and its 200-day moving average is $1.11. NanoString Technologies has a twelve month low of $0.05 and a twelve month high of $11.78. The firm has a market cap of $5.07 million, a P/E ratio of -0.03 and a beta of 1.24.
Institutional Investors Weigh In On NanoString Technologies
A number of institutional investors have recently modified their holdings of NSTG. Advisor Group Holdings Inc. lifted its holdings in NanoString Technologies by 21.1% in the first quarter. Advisor Group Holdings Inc. now owns 4,595 shares of the biotechnology company’s stock valued at $162,000 after buying an additional 800 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of NanoString Technologies by 38.1% in the 1st quarter. JPMorgan Chase & Co. now owns 86,603 shares of the biotechnology company’s stock valued at $3,009,000 after purchasing an additional 23,872 shares during the period. AlphaCrest Capital Management LLC bought a new stake in shares of NanoString Technologies during the 1st quarter valued at about $267,000. MetLife Investment Management LLC boosted its position in shares of NanoString Technologies by 57.4% during the 1st quarter. MetLife Investment Management LLC now owns 24,478 shares of the biotechnology company’s stock valued at $851,000 after purchasing an additional 8,930 shares in the last quarter. Finally, Lord Abbett & CO. LLC grew its stake in NanoString Technologies by 1.9% during the first quarter. Lord Abbett & CO. LLC now owns 139,659 shares of the biotechnology company’s stock worth $4,853,000 after purchasing an additional 2,542 shares during the period.
NanoString Technologies Company Profile
NanoString Technologies, Inc develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.
See Also
- Five stocks we like better than NanoString Technologies
- 3 Grocery Stocks That Are Proving They Are Still Essential
- United Airlines Soars on Earnings Beat
- Are Penny Stocks a Good Fit for Your Portfolio?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- What Are Growth Stocks and Investing in Them
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
